| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.2 |